Matchmaking & Expertise Session: New Antimicrobial Drugs and Vaccines

The first HERMES session focuses on the development of new antimicrobial drugs and vaccines. 

During the session, 11 organisations from across Europe will present their expertise, technologies and capabilities, and what they can contribute to future European consortia. As a participant, you will have the opportunity to identify complementary expertise, find potential consortium partners and make new connections for future project proposals. 

Who should attend? 

The session is aimed at companies and organisations planning to participate in upcoming Horizon Europe calls and other European research and innovation programmes, whether you are looking to build a consortium, join one or find specific expertise to strengthen a project idea. 

Join to: 

• Discover expertise and capabilities relevant to upcoming calls  

• Identify potential partners for your consortium  

• Explore how different organisations could contribute to future projects  

• Connect with companies, research organisations and innovation actors across Europe  

• Start conversations that could develop into future Horizon Europe proposals  

Calls in focus 

This HERMES session is particularly relevant for organisations interested in forming consortia and preparing proposals for: 

• HORIZON-HLTH-2027-01-DISEASE-05 
  Development of novel broad spectrum small molecule antiviral therapeutics for pathogens with epidemic potential  

• HORIZON-HLTH-2027-01-DISEASE-06 
  Development of monoclonal antibodies to prevent and treat infections from Flaviviridae  

• HORIZON-HLTH-2027-01-DISEASE-07 
  Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga Viridae  

• HORIZON-HLTH-2027-01-DISEASE-08 
  Development of innovative antimicrobials against critical pathogens resistant to antimicrobials  

• EUP OHAMR
  European Partnership on One Health Antimicrobial Resistance joint transnational call 2027 

Meet potential partners and complementary expertise 

The first HERMES session brings together 11 organisations from across Europe with expertise relevant to the development of antimicrobial drugs and vaccines: 

• From surface shaving of intact pathogens to epitope-guided vaccine antigen candidates
  Roger Karlsson, Sahlgrenska University Hospital
• First-in class virulence factor inhibition
  Rory Triniman, Veirulence Ltd
• Effective next-generation antibacterials for all
  Alan Hennessy, GARPD 
• One Health epidemiology for reducing antimicrobial use and resistance in aquaculture
  Fernando Mardones, University of Edinburgh
• Avenues for AMR research and clinical trials
  Jesse J. Waggoner, IRCCS-Negrar 
• Cutting-Edge Therapies to Combat Emerging Bacterial Pathogens
  Concepción González-Bello ,CiQUS
• Dynamic Antimicrobial Nanonmaterials
  Ignacio Insua, CiQUS
• The broader health, economic and societal impact of investments in infectious disease prevention, diagnostics and treatment
  Cornelis Boersma, Health-Ecore
• siRNA therapeutics – from bench to bedside
  Julia Grönros, Ribocure 
• Advancing Anti-Infective Research: Integrating Infection Biology, Antimicrobials and Vaccines
  Nadine Kraupner, RISE
• Environmental dimensions of AMR and One health: understanding evolution, emergence and dissemination of AMR
  Nachiket P. Marathe, Institute of Marine Research
• AMR Project Portfolio of the European Vaccine Initiative
  Irina Meln, European Vaccine Initiative (EVI) 

Meet the experts

Each organisation will give a short expert presentation focusing on its core expertise, technologies and capabilities, potential contributions to future European consortia, and the types of partnerships and roles it is seeking. 

About HERMES 

HERMES – Horizon Europe Matchmaking and Expertise Session is a meeting series organised by RISE to strengthen European collaboration and facilitate early consortium building for upcoming Horizon Europe calls and other European research and innovation programmes. 

By making relevant expertise and capabilities visible at an early stage, HERMES aims to help organisations find complementary partners and create new opportunities for collaborative project development.